Sovato Health is a technology company.
Sovato Health has raised $41.0M across 1 funding round.
Sovato Health has raised $41.0M in total across 1 funding round.
Sovato Health has raised $41.0M in total across 1 funding round.
Sovato Health's investors include Beringea, Vitalize Venture Group.
Sovato Health is a healthcare technology company that builds a comprehensive, robot-agnostic platform enabling safe, scalable remote robotic-assisted surgery and procedures.[1][2][4] It connects people, robotic systems, digital tools, and clinical data into a single ecosystem, serving healthcare organizations, surgeons, care teams, and patients to solve the problem of limited access to expert surgical care in underserved areas.[1][2][5] By orchestrating workflows, providing surgical-grade fiberoptic networks, and ensuring low-latency connectivity, Sovato extends the reach of skilled surgeons, demonstrated through milestones like 500-mile preclinical procedures in June 2024 and a 2,000-mile wet-lab study in July 2025, alongside an oversubscribed Series B funding round in November 2025 signaling strong growth momentum.[2][3][6]
Sovato Health was founded in 2022 in Santa Barbara, California, by co-founders Cynthia Perazzo, MBA (CEO), and Yulun Wang, PhD, a serial entrepreneur who pioneered Computer Motion (merged with Intuitive Surgical) and InTouch Health (acquired by Teladoc Health).[2][5][7] The idea emerged from Wang's legacy in robotics and telehealth, evolving into Sovato's mission to democratize high-quality surgical access through remote programs, building on early preclinical successes like multi-specialty procedures over 500 miles using Virtual Incision's MIRA system.[2][5] Pivotal moments include Beringea U.S. investment in 2024 and partnerships demonstrating viability, such as with LivsMed for 2,000-mile telesurgery in 2025.[2][6]
Sovato rides the telesurgery trend fueled by robotic advancements, global surgeon shortages, and demand for equitable healthcare access, amplified by post-pandemic telehealth adoption.[1][2][9] Timing aligns with maturing RAS ecosystems and 5G/fiber networks, enabling economically viable remote programs amid rising minimally invasive surgery needs.[3][6] Market forces like regulatory guidelines (e.g., Sovato-co-authored benchmarks) and partnerships with robotics firms (LivsMed, Virtual Incision) and telcos (AT&T) favor scalability, positioning Sovato to influence ecosystems by standardizing remote surgery infrastructure and driving adoption through confidence-building demos.[3][5][7]
Sovato is poised to lead telesurgery commercialization post-Series B, expanding platform integrations, clinical trials, and global deployments to make expert care ubiquitous.[3][9] Trends like AI-enhanced workflows, multi-robot fleets, and regulatory tailwinds will accelerate growth, potentially evolving Sovato into the de facto orchestrator for remote procedures, transforming surgical access from a vision to standard care.[1][8] This builds on its purpose-built tech, connecting robotics and expertise anywhere to power sustainable healthcare scale.
Sovato Health has raised $41.0M across 1 funding round. Most recently, it raised $41.0M Series B in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2025 | $41.0M Series B | Beringea, Vitalize Venture Group |